Welcome to LookChem.com Sign In|Join Free

CAS

  • or

773094-77-2

Post Buying Request

773094-77-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

773094-77-2 Usage

Physical state

Colorless to pale yellow liquid

Uses

Intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds

Health hazards

Skin and eye irritant, harmful if swallowed or inhaled

Safety precautions

Handle with care and follow proper safety guidelines

Environmental impact

Limited water solubility, may accumulate in aquatic environments and pose risks

Check Digit Verification of cas no

The CAS Registry Mumber 773094-77-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,0,9 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 773094-77:
(8*7)+(7*7)+(6*3)+(5*0)+(4*9)+(3*4)+(2*7)+(1*7)=192
192 % 10 = 2
So 773094-77-2 is a valid CAS Registry Number.

773094-77-2Relevant articles and documents

META-AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS PAN INTEGRIN ANTAGONISTS

-

Page/Page column 71, (2017/07/31)

The present disclosure provides pharmaceutical agents of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such pharmaceutical agents. Methods of using the pharmaceutical agents for the treatment of a variety of diseases and disorders are also provided.

Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives

-

Page/Page column 38, (2010/11/23)

This invention is concerned with compounds of the formula wherein A, B1, B2, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Synthesis of symmetrical tetraaryltetranaphtho[2,3]porphyrins

Finikova, Olga S.,Aleshchenkov, Sergei E.,Brinas, Raymond P.,Cheprakov, Andrei V.,Carroll, Patrick J.,Vinogradov, Sergei A.

, p. 4617 - 4628 (2007/10/03)

A new method of synthesis of meso-tetraaryltetranaphtho[2,3]porphyrins (Ar4TNP) has been developed. Ar4TNPs with peripheral functional groups are obtained by oxidative aromatization of meso-tetraarylporphyrins in which pyrrole units

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 773094-77-2